Kimberly Gentile, VP of Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 25,000 shares at $40.02 ($1.0M) on 2018-06-15, disclosed to the SEC on 2018-06-19.
Open-market sale of $1.0M BHVN by VP of Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.02 | 12,500 | $500K | 50.0% |
| 2 | $40.02 | 12,500 | $500K | 50.0% |
| Total | $40.02 avg | 25,000 | $1.0M | 100% |
| Filing → |
| BHVN | SELL | 2020-06-17 | $1.7M | — | Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2019-11-22 | $2.7M | — | Filing → |